| Literature DB >> 34295198 |
Nageh Shehata1, Salah Mahmoud Saleh1, Ahmed M Kamal2, Omnia Kamal Awad1.
Abstract
BACKGROUND: Epilepsy, the most common neurological disorder in children, may present with many psychiatric comorbidities, the most common of which is depression. AIM OF THE WORK: We evaluated the frequency of depressive symptoms in epileptic children, with regard to the possible association between depression and their demographic data or seizure-related variables. PATIENTS AND METHODS: This cohort study was conducted on 80 children (6-13 years old) diagnosed as idiopathic epilepsy and were regularly recruiting the pediatric neurology clinic at Minya University Children Hospital. The Structured Birleson Depression Scale Questionnaire was used for assessment of presence of depressive symptoms, and Quality Of Life in Epilepsy (QOLIE-31) score was used to assess quality of life in those patients.Entities:
Keywords: depressive symptoms; epileptic children; quality of life
Year: 2021 PMID: 34295198 PMCID: PMC8290486 DOI: 10.2147/RMHP.S301058
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Comparison Between the 2 Studied Groups Regarding the Socio-Demographic Data
| Variable | All Patients N= 80 | Group (A) N=30 | Group (B) N=50 | P-value | |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
| Age | Range | 6–13 | 10–13 | 6–9 | >0. 001 |
| Mean ± SD | 11.25 ± 1.89 | 13.3 ± 1.1 | 10 ± 0.83 | ||
| Sex | Males | 34 (42.5%) | 11 (36.7%) | 23 (46.0%) | >0.4 |
| Females | 46 (57.5%) | 19 (63.3%) | 27 (54.0%) | ||
| Residence | Urban | 45 (56.3%) | 11 (36.7%) | 34 (68.0%) | >0.006 |
| Rural | 35 (43.7%) | 19 (63.3%) | 16 (32.0%) | ||
| Educational level | None | 20 (25%) | 7 (23.3%) | 13 (26.0%) | >0.9 |
| Primary | 20 (25%) | 7 (23.3%) | 13 (26.0%) | ||
| Preparatory | 26 (32.5%) | 11 (36.7%) | 15 (30.0%) | ||
| Vocational | 14 (17.5%) | 5 (16.7%) | 9 (18.0%) | ||
| Family history | None | 48 (60%) | 17 (56.7%) | 31 (62.0%) | >0.3 |
| Of epilepsy only | 23 (28.7%) | 7 (23.3%) | 16 (32.0%) | ||
| Of mood disorders only | 7 (8.8%) | 6 (20.0%) | 1 (2.0%) | ||
| Positive for both | 2 (2.5%) | 0 (0.0%) | 2 (4.0%) | ||
| Past history of mood disorders | Positive | 26 (32.5%) | 24 (80.0%) | 2 (6.7%) | >0.03 |
| Negative | 54 (67.5%) | 6 (20.0%) | 48 (93.3%) | ||
Figure 1Types and frequency of depressive symptoms in the epileptic patients.
Comparison Between the 2 Studied Groups Regarding the Clinical Epilepsy-Related Variables
| Variable | All Patients N= 80 | Group (A) N=30 | Group (B) N=50 | ||
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
| Age at onset (years) | Mean± SD | 11±4.09 | 11.53±3.53 | 10.43±5.54 | >0.363 |
| Duration of epilepsy | <3 years | 43 (53.8%) | 7 (23.3%) | 36 (72.0%) | >0.01 |
| >3 years | 37 (46.3%) | 23 (76.7%) | 14 (28.0%) | ||
| Type of seizure | Partial | 20 (25%) | 7 (23.3%) | 13 (26.0%) | >0.79 |
| Generalized | 60 (75%) | 23 (76.7%) | 37 (74.0%) | ||
| Seizure frequency | Controlled [interval between seizures > 1year] | 45 (56.3%) | 7 (23.3%) | 38 (76.0%) | >0.01 |
| Not controlled [interval between seizures < 1year] | 35 (43.7%) | 23 (76.7%) | 12 (24.0%) | ||
| EEG findings | Positive | 45 (56.3%) | 20 (66.7%) | 25 (50.0%) | >0.146 |
| Negative | 35 (43.7%) | 10 (33.3%) | 25 (50.0%) | ||
| Antiepileptic drugs | Mono-therapy | 41 (51.2%) | 12 (40.0%) | 29 (58.0%) | >0119 |
| Poly-therapy | 39 (48.8%) | 18 (60.0%) | 21 (42.0%) | ||
| Carbamazepine | 51 (63.7%) | 24 (80%) | 27 (54%) | ||
| Sodium valproate | 48 (60%) | 16 (53.3%) | 32 (64%) | ||
| Phenytoin | 15 (18.7%) | 6 (20%) | 9 (18%) | ||
| Clonazepam | 30 (37.5%) | 10 (33.3%) | 20 (40%) | ||
| Phenobarbital | 15 (18.7%) | 5 (16.7%) | 10 (20%) | ||
| Ethosuximide | 12 (15%) | 4 (13.3%) | 8 (16%) | ||
| Seizure-free period (months) | <6 | 59 (73.7%) | 24 (80.0%) | 35 (70.0%) | >0.325 |
| >6 | 21 (26.3%) | 6 (20.0%) | 15 (30.0%) | ||
Figure 2Distribution of patients according to the duration of epilepsy.
Comparison Between the 2 Studied Groups Regarding Variables of Epilepsy (Related to the Psychosocial Aspect)
| Variable | All Patients N=80 | Group (A) N=30 | Group (B) N=50 | ||
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | |||
| Seizures occurred in front of peers | Yes | 54 (67.5%) | 25 (83.3%) | 29 (58.0%) | >0.019 |
| No | 26 (32.5%) | 5 (16.7%) | 21 (42.0%) | ||
| Affected patient’s social life | Yes | 40 (50%) | 22 (73.3%) | 18 (36.0%) | >0.001 |
| No | 40 (50%) | 8 (26.7%) | 32 (64%) | ||
| Affected patient’s education | Yes | 47 (58.7%) | 22 (73.3%) | 25 (50.0%) | > 0.04 |
| No | 33 (41.3%) | 8 (26.7%) | 25 (50.0%) | ||
| Physical injury with seizures | Yes | 51 (63.7%) | 23 (76.7%) | 28 (56.0%) | > 0.063 |
| No | 29 (36.3%) | 7 (23.3%) | 22 (44.0%) | ||
| Urinary incontinence with Seizures | Yes | 35 (43.8%) | 13 (43.3%) | 22 (44.0%) | > 0.954 |
| No | 45 (56.3%) | 17 (56.7%) | 28 (56.0%) | ||
| Suicidal tendency | None | 64 (80%) | 14 (46.7%) | 50 (100.0%) | <0.001 |
| Wish | 9 (11.3%) | 9 (30.0%) | 0 (0.0%) | ||
| Ideation±Intent | 7 (8.7%) | 7 (23.3%) | 0 (0.0%) | ||
Comparison Between the 2 Studied Groups Regarding the Mean Scores of Quality of Life in Epilepsy (QOLIE-31)
| Variable | Group (A) N=30 | Group (B) N=50 | P-value |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Overall score | 59.53 ± 17.59 | 77.6 ± 7.1 | <0.001 |
| Seizure worry | 51.82 ± 32.77 | 6.04 ± 1.1 | <0.001 |
| Overall QOL | 54.27 ± 12.67 | 9.8 ± 1.7 | <0.001 |
| Emotional well-being | 57.86 ± 22.74 | 11.7 ± 1.8 | <0.001 |
| Energy/fatigue | 52.10 ± 13.40 | 9.8 ± 1.2 | <0.001 |
| Cognitive functioning | 61.95 ± 23.94 | 21.3 ± 3.3 | <0.001 |
| Medication effects | 88.08 ± 22.92 | 2.4 ± 0.48 | <0.001 |
| Social functioning | 64.98 ± 28.36 | 16.2 ± 2.6 | <0.001 |